Persistence of viral RNA in lymph nodes in ART-suppressed SIV/SHIV-infected Rhesus Macaques

[1]  B. Sherman,et al.  Defective HIV-1 proviruses produce viral proteins , 2020, Proceedings of the National Academy of Sciences.

[2]  S. Gianella,et al.  HIV persists throughout deep tissues with repopulation from multiple anatomical sources. , 2020, The Journal of clinical investigation.

[3]  Nancy R. Zhang,et al.  Elite control of HIV is associated with distinct functional and transcriptional signatures in lymphoid tissue CD8+ T cells , 2019, Science Translational Medicine.

[4]  S. Hughes,et al.  HIV-1 in lymph nodes is maintained by cellular proliferation during antiretroviral therapy. , 2019, The Journal of clinical investigation.

[5]  K. Reimann,et al.  Lack of therapeutic efficacy of an antibody to α4β7 in SIVmac251-infected rhesus macaques , 2019, Science.

[6]  P. Lemey,et al.  HIV Rebound Is Predominantly Fueled by Genetically Identical Viral Expansions from Diverse Reservoirs. , 2019, Cell host & microbe.

[7]  R. Siliciano,et al.  The Landscape of Persistent Viral Genomes in ART-Treated SIV, SHIV, and HIV-2 Infections. , 2019, Cell host & microbe.

[8]  G. Alter,et al.  A versatile high-throughput assay to characterize antibody-mediated neutrophil phagocytosis , 2019, Journal of immunological methods.

[9]  S. Migueles,et al.  Longitudinal HIV sequencing reveals reservoir expression leading to decay which is obscured by clonal expansion , 2019, Nature Communications.

[10]  B. Foley,et al.  Persistent Viral Reservoirs in Lymphoid Tissues in SIV-Infected Rhesus Macaques of Chinese-Origin on Suppressive Antiretroviral Therapy , 2019, Viruses.

[11]  R. Siliciano,et al.  A novel quantitative approach for measuring the reservoir of latent HIV-1 proviruses , 2019, Nature.

[12]  M. Robb,et al.  Prevention of SIVmac251 reservoir seeding in rhesus monkeys by early antiretroviral therapy , 2018, Nature Communications.

[13]  S. Lewin,et al.  Functional cure of HIV: the scale of the challenge , 2018, Nature Reviews Immunology.

[14]  G. Alter,et al.  Antibody and TLR7 Agonist Delay Viral Rebound in SHIV-Infected Monkeys , 2018, Nature.

[15]  L. Picker,et al.  Early antiretroviral therapy limits SIV reservoir establishment to delay or prevent post-treatment viral rebound , 2018, Nature Medicine.

[16]  R. Schinazi,et al.  Simian Immunodeficiency Virus Persistence in Cellular and Anatomic Reservoirs in Antiretroviral Therapy-Suppressed Infant Rhesus Macaques , 2018, Journal of Virology.

[17]  G. Alter,et al.  Immune Correlate-Guided HIV Vaccine Design. , 2018, Cell host & microbe.

[18]  E. Wherry,et al.  Identification and characterization of HIV-specific resident memory CD8+ T cells in human lymphoid tissue , 2018, Science Immunology.

[19]  M. Paiardini,et al.  Lymph Node Cellular and Viral Dynamics in Natural Hosts and Impact for HIV Cure Strategies , 2018, Front. Immunol..

[20]  R. Ribeiro,et al.  Dynamics of Simian Immunodeficiency Virus Two-Long-Terminal-Repeat Circles in the Presence and Absence of CD8+ Cells , 2018, Journal of Virology.

[21]  G. Alter,et al.  Systems serology: profiling vaccine induced humoral immunity against HIV , 2017, Retrovirology.

[22]  R. Koup,et al.  HIV-Specific CD8+ T Cells Exhibit Reduced and Differentially Regulated Cytolytic Activity in Lymphoid Tissue , 2017, Cell reports.

[23]  J. Lifson,et al.  Defining total-body AIDS-virus burden with implications for curative strategies , 2017, Nature Medicine.

[24]  B. Korber,et al.  Protection against a mixed SHIV challenge by a broadly neutralizing antibody cocktail , 2017, Science Translational Medicine.

[25]  Mario Roederer,et al.  Trispecific broadly neutralizing HIV antibodies mediate potent SHIV protection in macaques , 2017, Science.

[26]  J. Mellors,et al.  Single-cell analysis of HIV-1 transcriptional activity reveals expression of proviruses in expanded clones during ART , 2017, Proceedings of the National Academy of Sciences.

[27]  M. Nussenzweig,et al.  Early antibody therapy can induce long-lasting immunity to SHIV , 2017, Nature.

[28]  Ben Murrell,et al.  Antibody 10-1074 suppresses viremia in HIV-1-infected individuals , 2017, Nature Medicine.

[29]  G. Alter,et al.  Systems serology for evaluation of HIV vaccine trials , 2017, Immunological reviews.

[30]  Jeffrey M. Gerold,et al.  Ad26/MVA Therapeutic Vaccination with TLR7 Stimulation in SIV-Infected Rhesus Monkeys , 2016, Nature.

[31]  B. Walker,et al.  Single-Cell Characterization of Viral Translation-Competent Reservoirs in HIV-Infected Individuals. , 2016, Cell host & microbe.

[32]  J. Lifson,et al.  Rapid Inflammasome Activation following Mucosal SIV Infection of Rhesus Monkeys , 2016, Cell.

[33]  R. Siliciano,et al.  HIV reservoirs: what, where and how to target them , 2015, Nature Reviews Microbiology.

[34]  M. Lederman,et al.  Origin of Rebound Plasma HIV Includes Cells with Identical Proviruses That Are Transcriptionally Active before Stopping of Antiretroviral Therapy , 2015, Journal of Virology.

[35]  Jerome H. Kim,et al.  Dissecting Polyclonal Vaccine-Induced Humoral Immunity against HIV Using Systems Serology , 2015, Cell.

[36]  R. Siliciano,et al.  The Remarkable Stability of the Latent Reservoir for HIV-1 in Resting Memory CD4+ T Cells. , 2015, The Journal of infectious diseases.

[37]  Michael S. Seaman,et al.  Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117 , 2015, Nature.

[38]  J. Hoxie,et al.  Whole-body immunoPET reveals active SIV dynamics in viremic and antiretroviral therapy–treated macaques , 2015, Nature Methods.

[39]  Jennifer A. Johnson,et al.  Induction of HIV-1-specific mucosal immune responses following intramuscular recombinant adenovirus serotype 26 HIV-1 vaccination of humans. , 2015, The Journal of infectious diseases.

[40]  G. Silvestri,et al.  Persistence of Virus Reservoirs in ART-Treated SHIV-Infected Rhesus Macaques after Autologous Hematopoietic Stem Cell Transplant , 2014, PLoS pathogens.

[41]  Jinyan Liu,et al.  Rapid Seeding of the Viral Reservoir Prior to SIV Viremia in Rhesus Monkeys , 2014, Nature.

[42]  Alan S Perelson,et al.  Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissues , 2014, Proceedings of the National Academy of Sciences.

[43]  Michael S. Seaman,et al.  Therapeutic Efficacy of Potent Neutralizing HIV-1-Specific Monoclonal Antibodies in SHIV-Infected Rhesus Monkeys , 2013, Nature.

[44]  Jerome H. Kim,et al.  Protective Efficacy of a Global HIV-1 Mosaic Vaccine against Heterologous SHIV Challenges in Rhesus Monkeys , 2013, Cell.

[45]  Sarah B. Laskey,et al.  Replication-Competent Noninduced Proviruses in the Latent Reservoir Increase Barrier to HIV-1 Cure , 2013, Cell.

[46]  Matthew S. Lewis,et al.  Immune clearance of highly pathogenic SIV infection , 2013, Nature.

[47]  C. Bailey-Kellogg,et al.  High-throughput, multiplexed IgG subclassing of antigen-specific antibodies from clinical samples. , 2012, Journal of immunological methods.

[48]  Jerome H. Kim,et al.  Vaccine Protection Against Acquisition of Neutralization-Resistant SIV Challenges in Rhesus Monkeys , 2011, Nature.

[49]  K. Mansfield,et al.  Durable Mucosal Simian Immunodeficiency Virus-Specific Effector Memory T Lymphocyte Responses Elicited by Recombinant Adenovirus Vectors in Rhesus Monkeys , 2011, Journal of Virology.

[50]  J. Clements,et al.  Replication-Competent Simian Immunodeficiency Virus (SIV) Gag Escape Mutations Archived in Latent Reservoirs during Antiretroviral Treatment of SIV-Infected Macaques , 2011, Journal of Virology.

[51]  Susan Moir,et al.  Pathogenic mechanisms of HIV disease. , 2011, Annual review of pathology.

[52]  D. Irvine,et al.  A robust, high-throughput assay to determine the phagocytic activity of clinical antibody samples. , 2010, Journal of immunological methods.

[53]  Timothy L. Hayes,et al.  Viral Sanctuaries during Highly Active Antiretroviral Therapy in a Nonhuman Primate Model for AIDS , 2009, Journal of Virology.

[54]  Hui Li,et al.  Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection , 2008, Proceedings of the National Academy of Sciences.

[55]  Qingsheng Li,et al.  Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells , 2005, Nature.

[56]  Mario Roederer,et al.  Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection , 2005, Nature.

[57]  J. Clements,et al.  The central nervous system is a viral reservoir in simian immunodeficiency virus-infected macaques on combined antiretroviral therapy: A model for human immunodeficiency virus patients on highly active antiretroviral therapy , 2005, Journal of NeuroVirology.

[58]  S. Lillard,et al.  In-situ sampling and separation of RNA from individual mammalian cells. , 2000, Analytical chemistry.

[59]  Anthony S. Fauci,et al.  AIDS: Re-emergence of HIV after stopping therapy , 1999, Nature.

[60]  J. Lisziewicz,et al.  Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy , 1999, Nature Medicine.

[61]  K Watanabe,et al.  RNA chip: quality assessment of RNA by microchannel linear gel electrophoresis in injection-molded plastic chips. , 1998, Clinical chemistry.

[62]  D. Richman,et al.  Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. , 1997, Science.

[63]  R Brookmeyer,et al.  Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. , 1997, Science.

[64]  A. Haase,et al.  Simian immunodeficiency virus burden in tissues and cellular compartments during clinical latency and AIDS. , 1997, The Journal of infectious diseases.

[65]  R. Siliciano,et al.  Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection , 1997, Nature.

[66]  Alan S. Perelson,et al.  Quantitative Image Analysis of HIV-1 Infection in Lymphoid Tissue , 1996, Science.

[67]  Steven Wolinsky,et al.  Analysis of human immunodeficiency virus-infected tissues by amplification and in situ hybridization reveals latent and permissive infections at single-cell resolution. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[68]  A. Fauci,et al.  Lymphoid organs function as major reservoirs for human immunodeficiency virus. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[69]  V. Gallo,et al.  Glutamate as a Putative Transmitter in the Cerebellum: Stimulation by GABA of Glutamic Acid Release from Specific Pools , 1981, Journal of neurochemistry.

[70]  J. Merrill.  Hazards of ethacrynic acid. , 1970, Journal of the American Medical Association (JAMA).

[71]  Alan S. Perelson,et al.  The decay of the latent reservoir of replication-competent HIV-1 is inversely correlated with the extent of residual viral replication during prolonged anti-retroviral therapy , 2000, Nature Medicine.

[72]  A. Haase,et al.  Population biology of HIV-1 infection: viral and CD4+ T cell demographics and dynamics in lymphatic tissues. , 1999, Annual review of immunology.

[73]  O. Vejbora.  [Changes in reactivity of experimental animals with delayed type of hypersensitivity]. , 1968, Sbornik vedeckych praci Lekarske fakulty Karlovy university v Hradci Kralove.